جست‌وجوی استاد و پژوهشگر

David Junckerمشاهده پروفایل

استاد

• Microfluidics
• Nanotechnology
• Lab-on-a-Chip
• +۶ مورد دیگر

David Juncker is a Professor and Department Chair of the Department of Biomedical Engineering at McGill University. He serves as a Principal Investigator at the McGill University & Genome Quebec Innovation Centre and holds associate memberships in the Department of Neurology and Neurosurgery, Department of Electrical and Computer Engineering, Division of Experimental Medicine, Department of Surgery, and Goodman Cancer Research Centre. His research focuses on micro- and nano-bioengineering technologies for bioanalysis, precision medicine, and organs-on-chips. Key areas include microfluidics, lab-on-a-chip devices, biomedical sensors, medical diagnostics, biomaterials, tissue engineering, and cancer biomarker discovery. His lab develops scalable antibody microarrays, self-powered diagnostic platforms, microfluidic probes for brain tissue perfusion, and nanogradients for neuronal navigation, with applications in cancer diagnostics, global health, and neuroscience. Recent publications (2023-2025) reveal strong emphasis on extracellular vesicle analysis, single-cell proteomics, 3D-printed microfluidic/organ-on-a-chip systems, and capillary-driven circuits. Key trends include low-cost point-of-care diagnostics, advanced circulating tumor cell isolation methods, and biomimetic synthetic vesicles for drug delivery, demonstrating translational potential in early disease detection. Dr. Juncker leads a highly interdisciplinary team comprising undergraduate and graduate students, post-doctoral fellows, and staff from diverse scientific, engineering, and cultural backgrounds. His lab actively recruits Canadian/permanent resident graduate students for projects on single extracellular vesicle and protein detection in cancer and infectious diseases, leveraging microfluidics and wearables for biomarker discovery. The Juncker Lab operates from the McGill University & Genome Quebec Innovation Centre (740 Dr. Penfield Avenue, Room 6206). It maintains a collaborative, multicultural environment focused on developing transformative micro- and nano-bioengineering technologies with significant potential impact on human health diagnostics and treatment.

Karen S. Andersonمشاهده پروفایل

استاد

• Cancer Immunology
• Breast Cancer
• HPV-related Cancers
• +۵ مورد دیگر

Karen S. Anderson, M.D., Ph.D. is a Professor of Medicine at Mayo Clinic in Phoenix, Arizona, where she serves as a Contract Physician in the Division of Hematology/Oncology within the Department of Internal Medicine. Her clinical practice focuses on breast cancer, and she is affiliated with the Mayo Clinic Comprehensive Cancer Center and the Breast Clinic. As an active researcher, Dr. Anderson leads clinical trials in breast cancer immunotherapy and biomarker development. Dr. Anderson's educational background includes: Medical Scientist Training Program (MD), Duke University School of Medicine (1994) Ph.D. in Microbiology and Immunology, Duke University (1994) BA in Chemistry, University of Virginia (1986) Internship and Residency in Internal Medicine, Brigham and Women's Hospital, Boston Fellowship in Adult Hematology and Oncology, Dana Farber Cancer Institute Dr. Anderson's research focuses on cancer immunology with particular emphasis on breast cancer biomarkers, ovarian cancer biomarkers, pancreatic cancer biomarkers, cancer vaccines, and HPV-related cancers. Her work spans from basic immunology to clinical applications, with a strong focus on translating laboratory findings into clinical practice. She has developed innovative approaches for early cancer detection and has been instrumental in advancing breast cancer immunotherapy through clinical trials. Analysis of Dr. Anderson's recent publications reveals a consistent focus on breast cancer immunology, biomarker discovery, and HPV-related cancers. Her work integrates molecular biology, immunology, and clinical oncology to develop novel diagnostic and therapeutic approaches. Notably, her research has expanded to include computational approaches for neoantigen prediction and has addressed public health challenges including HPV-related cancer screening and even COVID-19 vaccine strategies. Dr. Anderson has received several prestigious awards: Outstanding Faculty Mentor Arizona State University Faculty Women's Association (2020) Chief Resident West Roxbury VA Hospital (1996) Phi Beta Kappa University of Virginia (1986) Merck Scholar (1986) Alpha Omega Alpha Honor Medical Society (1986) Echols Scholar University of Virginia (1982) Dr. Anderson has been actively involved in mentoring students and early-career researchers, serving on numerous thesis committees at Arizona State University across multiple departments including Molecular and Cellular Biology, Chemistry, and the Barrett Honors College. Her research is supported by multiple grants from the National Cancer Institute, including her role as Co-Chair of the Breast and Gynecologic Cancers Collaborative Group within the Early Detection Research Network. Dr. Anderson is a key member of the Arizona Biomarker Alliance Executive Committee and has established collaborative research teams focused on cancer biomarker discovery and validation. Her laboratory work integrates protein microarray technology, immunology, and cancer genomics to develop novel diagnostic and therapeutic approaches for breast and HPV-related cancers.

Annette Byrneمشاهده پروفایل

استاد

• Precision Medicine
• Molecular Imaging
• Angiogenesis
• +۷ مورد دیگر

Professor Annette Byrne is a leading academic at RCSI University of Medicine and Health Sciences , where she serves as Professor of Physiology and Head of the Precision Cancer Medicine (PCM) Group. She has held this position since 2019 after progressing through roles as Lecturer (2008), Senior Lecturer (2013), and Associate Professor (2017). Her research focuses on precision medicine approaches for colorectal and brain cancers , integrating multi-modality molecular imaging , Next Generation Sequencing , and patient-derived xenograft models . PhD in Cell Biology (University of York, 1999) John Kerner Fellowship in Gynaecologic Oncology (UCSF, 1999-2001) Scientist at Pharmacyclics Inc. (2001-2003) Senior Scientist at Angion Biomedica Corp. (2003-2005) Principal Investigator at UCD Conway Institute (2005-2008) Her research interest lies in precision cancer medicine , particularly elucidating predictive biomarkers (genomic, transcriptomic, proteomic) and identifying novel therapeutic targets . Key methodologies include radiomics , fluorescence-guided surgery , and systems modeling of apoptosis pathways. She has pioneered Ireland's first Tumour Xenograft Facility and Translational In Vivo Imaging Centre . Recent publications highlight her work on cross-species radiomics , cell-free DNA analysis , and glioblastoma microenvironment subtyping . Her Marie Curie networks (Gliotrain, Glioresolve) and COLOSSUS project have trained 25+ PhD researchers in brain cancer therapeutics. Over €45M in national/international grants Member of Royal Irish Academy (2025) Highly cited in Cancer Discovery , Annals of Oncology , and Nature journals She supervises multiple PhD candidates and leads the RCSI Precision Cancer Medicine Group , which utilizes computational approaches and molecular imaging to improve cancer treatment outcomes. Her GLIORESOLVE and EDIReX projects focus on tumor microenvironment manipulation and distributed PDX infrastructure.

• Biomarkers
• Quantitative Analysis in Pathology
• Medical Data Interpretation
• +۵ مورد دیگر

Robert Camp is a Researcher at Yale School of Medicine , affiliated with the Department of Pathology . His work focuses on biomarkers , quantitative analysis , and automation in pathology . Education MD, Yale University School of Medicine (1997) PhD, Yale University School of Medicine, Immunology (1992) BA, Swarthmore College, Biology (1987) His research interests include tumor microenvironment , biomarker quantification , and histopathology standardization , with a focus on renal cell carcinoma and interstitial lung disease . Recent publications highlight automation tools like the AQUA System and X-Tile software for tumor subpopulation analysis . Scientific contributions include the Charles W. Bomfalk Prize for medical student teaching and leadership in the Breast Cancer Alliance . He has collaborated extensively with researchers such as David Rimm and Harriet Kluger on projects involving tumor vascularity and immunotherapy targets .

Griffin Weberمشاهده پروفایل

دانشیار

• Biomedical Informatics
• Social Network Analysis
• Team Science
• +۵ مورد دیگر

Griffin Weber, M.D., Ph.D., is an Associate Professor of Medicine and Biomedical Informatics at Harvard Medical School (HMS) and Beth Israel Deaconess Medical Center (BIDMC). He directs the Biomedical Research Informatics Core (BRIC) at BIDMC. His research focuses on expertise mining, social network analysis, and biomedical informatics. Key contributions include developing Profiles RNS (an open-source research networking platform) and i2b2 / SHRINE federated query tools for clinical data. He holds MD and PhD degrees from Harvard (2007), and earlier degrees in bioengineering and computer science. Education: SB in Bioengineering (Harvard, 2000), SM/PhD in Computer Science (Harvard, 2004/2005), MD (Harvard, 2007). He served as Harvard Medical School's first Chief Technology Officer, building educational platforms for 500+ courses. His work spans DNA microarrays, breast cancer tumor modeling, and EHR bias analysis. Research Interests: Leveraging informatics to improve healthcare through federated data systems, team science dynamics, and EHR analysis. Projects include Profiles RNS for researcher networks and i2b2 for clinical data queries across institutions. He explores biases in EHR data filtering and visualizing healthcare system dynamics in biomedical data. Grant Leadership: Principal investigator on NIH grants addressing EHR biases (R01LM013345), healthcare system dynamics (U01CA198934), and scientific workforce networks (U01GM112623). Collaborator on PCORI and NIH-funded initiatives. Awards: 2020 Fellow of the American College of Medical Informatics; 2011 Top Podium Presentation (AMIA); 2007 Medical Technology Award (Massachusetts Medical Society). Labs/Teams: Leads BRIC at BIDMC, collaborates on i2b2/SHRINE, and contributes to the 4CE consortium for federated healthcare data analysis.

Jeremy Edwardsمشاهده پروفایل

استاد

• Pharmaceutical Chemistry
• Quantitative Biology
• Genomics
• +۵ مورد دیگر

Jeremy Edwards serves as a Professor in the Department of Chemistry at the University of New Mexico, where he maintains an active research program at the intersection of pharmaceutical chemistry, genomics, and computational biology. His work spans multiple disciplines with a particular focus on developing innovative technologies for DNA sequencing and analysis. Professor Edwards' research interests center around Pharmaceutical Chemistry, Quantitative Biology, and Genomic Technologies. His work has significantly contributed to the fields of metabolic engineering, genome sequencing, and systems biology. He has pioneered approaches in nanopore sequencing technology and developed computational frameworks for analyzing complex biological systems. His research group has made notable contributions to understanding metabolic networks through flux balance analysis and in silico modeling, with applications ranging from bacterial metabolism to mammalian systems. Analysis of Professor Edwards' publication record reveals a strong trend toward developing cutting-edge genomic technologies and computational approaches for biological analysis. His recent work focuses on spatial transcriptomics, nanopore sequencing innovations, viral genome surveillance, and target illumination for drug discovery. The publications demonstrate a consistent trajectory from foundational metabolic modeling work toward increasingly sophisticated genomic technologies and applications in drug target identification and validation. Professor Edwards has established himself as a leader in computational genomics with an extensive publication record including highly cited papers such as "In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data" (1297 citations) and "The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities" (1295 citations). His work on metabolic modeling has been particularly influential in systems biology. As an active researcher, Professor Edwards has mentored numerous students and collaborators, though specific student names aren't documented in the available materials. His research has attracted significant funding supporting the development of genomic technologies and computational approaches. His laboratory appears to focus on the intersection of bioinformatics, molecular biology, and engineering, with particular emphasis on next-generation sequencing technologies and their applications. Professor Edwards leads a research group that integrates computational modeling with experimental approaches to tackle challenges in genomic analysis and metabolic engineering. His team has developed innovative tools like the Sentieon Genomics Tools, described as "a fast and accurate solution to variant calling from next-generation sequence data." The group's work spans from fundamental research on DNA sequencing technologies to applied projects in viral surveillance and drug target identification.

Cameron A. Myhrvoldمشاهده پروفایل

استادیار

• CRISPR-based technologies
• Viral RNA studies
• Host-pathogen interactions
• +۷ مورد دیگر

Cameron A. Myhrvold is an Assistant Professor of Molecular Biology at Princeton University, leading the Myhrvold Lab. His research focuses on CRISPR-based technologies to study viral and host RNA, with applications in detecting and combating RNA viruses like SARS-CoV-2. He specializes in developing Cas13-based tools for multiplexed nucleic acid detection, host-pathogen interaction analysis, and RNA perturbation. Education: A.B. in Molecular Biology from Princeton University (undergraduate), Ph.D. in Systems Biology from Harvard University. His postdoctoral work at Harvard involved pioneering CRISPR-Cas13 technologies, leading to innovations like CARMEN, CARVER, and SHINE. Research interests include: CRISPR-based RNA editing, quantitative nucleic acid detection, systems biology of viral infections, and translating technologies for global health. His lab emphasizes deploying diagnostics in resource-limited settings and studying viral dynamics across diverse tissues and infection conditions. Notable achievements: Named NEBEC Emerging Young Investigator. His work has advanced field-deployable viral diagnostics and multiplexed RNA analysis tools. Collaborates with institutions like the Broad Institute and the CDC on pandemic response initiatives. Current projects include developing quantitative CARMEN variants for gene expression analysis, high-throughput screening of Cas13-virus interactions, and applying CRISPR tools to study influenza and SARS-CoV-2 in animal models.

Torsten Nielsenمشاهده پروفایل

استاد

• Sarcoma
• Breast Cancer
• Molecular Diagnostics
• +۷ مورد دیگر

Professor Torsten Nielsen is a clinician-scientist at the University of British Columbia 's Department of Pathology & Laboratory Medicine (Faculty of Medicine), based at Vancouver General Hospital and BC Cancer . He directs UBC's MD/PhD Program , contributes to cancer clinical trials with the Canadian Cancer Trials Group , and chairs the international Connective Tissue Oncology Society 's Research Committee. Key affiliations: UBC, Vancouver General Hospital, BC Cancer, Molecular and Advanced Pathology Core Academic focus: Translational research in sarcomas and breast cancer His research prioritizes translating genomic discoveries into clinical diagnostics and treatments, particularly for synovial sarcoma , breast cancer subtypes , and tenosynovial giant cell tumors . He develops FDA-cleared molecular assays like the PAM50 (Prosigna) test and leads pan-Canadian precision oncology initiatives . Collaborative efforts include work with Stanford, Leiden, and DKFZ Heidelberg. Recent publications highlight advancements in epigenetic therapies , immune biomarker validation , and synovial sarcoma pathogenesis . His lab's work on CSF1/CSF1R signaling inspired new treatment strategies for joint-destructive tumors. Scientific Awards: Fellow, Canadian Academy of Health Sciences Fellow, Royal Society of Canada As director of UBC's MD/PhD Program, he trains future clinician-scientists. His lab team includes experts in epigenomics , proteomics , and mouse modeling . Current projects focus on precision oncology for sarcomas and Ki67 standardization in breast cancer.

Lu Shin Wongمشاهده پروفایل

مدرس ارشد

• Biocatalysis
• Nanofabrication
• Chemical Biology
• +۳ مورد دیگر

Lu Shin Wong is a Senior Lecturer in Chemical Biology and Biological Chemistry at the University of Manchester's School of Chemistry, affiliated with the Manchester Institute of Biotechnology. He holds a PhD from the University of Southampton and has expertise in biocatalysis and nanofabrication. His research focuses on sustainable chemical processes, enzyme-driven reactions, and nanoscale material fabrication. Wong has held postdoctoral roles at Manchester and Northwestern University, and leads projects in biocatalytic applications, nanotechnology, and bioelectronics. Education: PhD in Organic and Analytical Chemistry (University of Southampton, 2005); BPharm (University of Nottingham, 1997); Postgraduate Diploma in Clinical Pharmacy (University of Bradford, 2001). Research Interests: Biocatalysis (enzyme-mediated organosilicon chemistry, sustainable oxidations); Nanofabrication (scanning probe lithography, polymer pen lithography). His work bridges biotechnology and nanotechnology, emphasizing sustainable synthesis and biomedical applications. Recent projects include the Manchester Bioelectronics Network and CRISPR-Cas technology integration into organic electronics. Key Achievements: Developed methods for protein immobilization using phosphopantetheinyl transferase, pioneered biocatalytic approaches to silicone polymer synthesis, and contributed to understanding stem cell behavior on nanostructured substrates. Active in interdisciplinary collaborations, including bioelectronics and mass spectrometry advancements.

Randolph Ashtonمشاهده پروفایل

استاد

• Neural tissue engineering
• Vascular tissue engineering
• Regenerative therapies for the central nervous system
• +۳ مورد دیگر

Randolph Ashton is a Professor in the Department of Biomedical Engineering at the University of Wisconsin-Madison College of Engineering. He directs the Stem Cell Bioprocessing and Regenerative Biomaterials Laboratory, where his team engineers novel materials and methodologies for lineage-specific differentiation of human pluripotent stem cells. His interdisciplinary research bridges biomaterials science, stem cell biology, and tissue engineering to develop regenerative therapeutic strategies. His educational background includes: PhD (2007) from Rensselaer Polytechnic Institute BS (2002) from Hampton University Ashton's research focuses on neural and vascular tissue engineering , with specialization in regenerative therapies for the central nervous system. His laboratory employs microfabrication, molecular biology, recombinant protein engineering, and automated live-cell imaging to investigate cellular microenvironmental factors regulating stem cell fate. Current work emphasizes developing high-throughput screening methods and tissue-engineered scaffolds for generating complex tissue structures in vitro. His recent publications reveal a strong trajectory in neural organoid development, CNS vascularization, and microphysiological systems. The research demonstrates quantitative approaches to understanding stem cell differentiation, with applications spanning from fundamental developmental biology to clinical regenerative medicine. Key technological innovations include advanced microelectrode arrays and high-throughput screening platforms for neural tissue engineering. Notable awards include: 2023 AIMBE Fellowship 2020 WARF Innovation Award 2018 UW-Madison College of Engineering Equity & Diversity Award 2017 NSF CAREER Award 2016 Regenerative Medicine Workshop Young Investigator Award Ashton actively mentors graduate students through thesis research (BME 890, BME 990) and teaches core courses including Biological Interactions with Materials (BME 430). His laboratory operates as an interdisciplinary team bringing together engineering, biology, and materials science expertise to develop regenerative therapies, with current focus on central nervous system applications and expanding interests in vascular and muscular tissues. The Stem Cell Bioprocessing and Regenerative Biomaterials Laboratory maintains active collaborations across disciplines and continues to develop novel approaches for high-order tissue structure generation using human pluripotent stem cells. Current research directions include expanding into vascular and muscular tissue systems while refining quantitative methodologies for stem cell microenvironment characterization.

Claudia Rangel-Escareñoمشاهده پروفایل

استاد مدعو

• Computational Biology
• Statistical Inference of Genetic Networks
• Bioinformatics
• +۵ مورد دیگر

Claudia Rangel-Escareño is an adjunct professor of mathematics at Claremont Graduate University’s Institute of Mathematical Sciences and director of the Computational Genomics Department at Mexico’s National Institute of Genomic Medicine. She holds a PhD in Mathematics from Claremont Graduate University, along with an MS and BS in Mathematics from the same institution and Universidad Autónoma Metropolitana, respectively. Her research focuses on probabilistic methods in computational biology, statistical inference of genetic networks, and bioinformatics. Key areas include microarray data analysis, state-space modeling for gene regulatory networks, and integrative genomics in cancer research. Recently, her work at the National Institute of Genomic Medicine has centered on microRNA expression in postmenopausal women to identify noninvasive biomarkers for osteoporosis diagnosis. Rangel-Escareño has 23 publications and three book chapters. She has presented at international venues like the Federal Institute of Technology in Zurich and Ludwig-Maximilians University, Munich. Her honors include National Council of Science and Technology Fellowship and membership in Mexico’s National Research System (SNI), Level I. She teaches Computational Methods for Molecular Biology Introduction to Scientific Computing Grants include support from the Carlos Slim Health Institute. Her computational genomics research spans collaborations across institutions, with a focus on translational applications in healthcare through genomic technologies.

Sara Ekمشاهده پروفایل

استاد

• Lymphoma
• B Cell Lymphomas
• Cancer and Oncology
• +۴ مورد دیگر

Sara Ek is a Professor and Deputy Head of Department at the Department of Immunotechnology within the Faculty of Engineering (LTH) at Lund University. She serves as Principal Investigator at the Lund University Cancer Centre (LUCC), Director of Create Health, and is a Researcher in the eSSENCE: The e-Science Collaboration. Her academic profile demonstrates a strong commitment to advancing cancer research, particularly in lymphoid malignancies. Dr. Ek's research program, "Cancer Target Group– molecular and functional analysis in lymphoid proliferative disorders," focuses on finding biological solutions to clinically important questions involving improved diagnosis, stratification, and treatment of lymphoma patients. Recognizing that cancer heterogeneity presents a major challenge to successful treatment, her team develops tools to capture this heterogeneity and identify variations in tumor-related signaling pathways and interactions with the immune microenvironment. This work involves close collaboration with clinicians to perform advanced molecular investigations using sequencing, spatial omics technologies, serum protein profiling, and functional screening of patient materials from clinical trials. Her publication record reveals a consistent trajectory of impactful research in lymphoma, particularly mantle cell lymphoma, with groundbreaking work on the SOX11 transcription factor as a diagnostic biomarker. More recently, her research has expanded into spatial analysis of tumor immune microenvironments across different cancer types, including ovarian cancer. This evolution demonstrates her ability to leverage emerging technologies to address complex questions in cancer biology. Active Projects: A cellular and molecular dissection of the lymphoma tumor immune microenvironment to understand and address treatment resistances (2025-2028) MULTIPLY: MULITlayer Predictive models for relapsed MCL after ibrutinib as first line therapy (2024-2027) Primary ibrutinib resistance in mantle cell lymphoma – translational immuno-oncology investigations (2024-2026) Dr. Ek manages the SpatialOmics@LU infrastructure facility and has organized multiple scientific events including the LUCC Immunology minisymposium on digital spatial profiling in February 2024, demonstrating her leadership in both research and academic community building.

• Genetics
• Molecular Biology
• Bioinformatics
• +۴ مورد دیگر

Sevinç AKÇAY is a Lecturer at the Department of Molecular Biology and Genetics in the Faculty of Arts and Sciences at Kırşehir Ahi Evran University , Turkey. She holds a PhD (2016) and MSc (2012) in Molecular Biology from the University of Pittsburgh , and a BSc (2008) in Biology from Ankara University . Research Focus: Genetics, Molecular Biology, and Bioinformatics, with emphasis on elastin gene mutations , cancer genomics , and computational disease modeling . Key Projects: Investigated Tiochlorosid and Malathion effects on cancer cell lines; led studies on epigenetic mechanisms and ferroptosis in cancer . Teaching: Offers courses in Genetic Engineering , Epigenetics , and CRISPR Technologies at both undergraduate and graduate levels. Collaborations: Works with international researchers like Zsolt Urban (University of Pittsburgh) and Emine Güven (Düzce University) on computational biology and genetic disorders.

Matthew R. Liberaمشاهده پروفایل

استاد

• Polymeric biomaterials
• Hydrogels
• Biomaterials-associated infection
• +۳ مورد دیگر

Matthew R. Libera is a Professor of Materials Science at the Stevens Institute of Technology , affiliated with the Schaefer School of Engineering and Science and the Department of Chemical Engineering and Materials Science . He directs the Laboratory for MultiScale Imaging (LMSI) , a facility specializing in TEM, SEM, AFM, and confocal imaging of soft materials. Education: Sc.D., MIT (1987) - Materials Science (Minor: Physics) S.M., MIT (1983) - Materials Science B.S., Lafayette College (1981) - Metallurgical Engineering His research spans polymeric biomaterials , hydrogels , and electron microscopy , focusing on infection-resistant biomaterials and microbial diagnostics. He has pioneered electron-beam lithography and electron energy-loss spectroscopy for soft-materials analysis. Recent work explores microgel-tethered molecular beacons , self-defensive hydrogel coatings , and biofilm mechanics . His publications emphasize biomaterials-associated infection and nanoscale imaging techniques. He has served as Associate Dean for Graduate Academics & Research (2013-2018) and held academic roles at IBM Research and MIT.

Zeinab Hosseinidoustمشاهده پروفایل

دانشیار

• Antimicrobial Resistance
• Bioengineering
• Biomaterials
• +۷ مورد دیگر

Zeinab Hosseinidoust is an Associate Professor in the Department of Chemical Engineering at McMaster University and holds the Canada Research Chair (Tier 2) in Bacteriophage Bioengineering. Her work bridges chemical and biomedical engineering to address antimicrobial resistance through innovative bacteriophage-based technologies. She leads the Hosseinidoust Research Group, which focuses on transforming phages into scalable products for healthcare, agriculture, and food safety. Education: Ph.D. from McGill University, postdoctoral training at Max Planck Institute for Intelligent Systems. Research Pillars: Phage Antimicrobials, Phage Biomaterials, Phage Diagnostics, and Aerosolized Phage Applications. Her 15 most recent articles (2024–2025) emphasize translational phage bioengineering, including high-throughput diagnostic platforms, antimicrobial microgels, and smart implant coatings. Key themes include Phage Therapy , Biomaterials Engineering , and Nano-Structured Antimicrobials , with subfields like 3D Bioprinting , Smart Textiles , and In Vivo Models . Awards: Canada Research Chair, Ontario Early Researcher Award, Dean’s Honor Roll for Teaching Excellence. Teaching: Courses in Heat Transfer (CHEMENG 3A04) and Health Solutions Design Projects II (IBEHS 2P03). Collaborative Affiliations: Core member of the Farncombe Institute for Digestive Health, associate member of the Michael DeGroote Institute for Infectious Disease Research, School of Biomedical Engineering, and CEPEM.